|
• May 2. The prescribing information for Enbrel (etabercept) is revised to include a boxed warning about infections. MedWatch Safety Information.
• April 29. FDA approves Amitiza (lubiprostone) for the treatment of irritable bowel syndrome with constipation in adult women aged 18 and over. FDA News
• April 28. Actavis Totowa LLC recalls all strengths of Digitek (digoxin tablets, USP), a drug used to treat heart failure and abnormal heart rhythms. MedWatch Safety Information
• April 25. FDA updates information to healthcare facilities and healthcare professionals about heparin and heparin-containing medical products. Information
• April 25. FDA approves Relistor (methylnaltrexone bromide) for opioid-induced constipation. FDA News
Previous News Items |
